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Oral glutathione supplementation 
drastically reduces Helicobacter-
induced gastric pathologies
Ellen De Bruyne1, Richard Ducatelle1, Dennis Foss2, Margaret Sanchez2, Myrthe Joosten1, 
Guangzhi Zhang1, Annemieke Smet1, Frank Pasmans1, Freddy Haesebrouck1,* & 
Bram Flahou1,*
Helicobacter (H.) suis causes gastric pathologies in both pigs and humans. Very little is known on the 
metabolism of this bacterium and its impact on the host. In this study, we have revealed the importance 
of the glutamate-generating metabolism, as shown by a complete depletion of glutamine (Gln) in the 
medium during H. suis culture. Besides Gln, H. suis can also convert glutathione (GSH) to glutamate, 
and both reactions are catalyzed by the H. suis γ-glutamyltranspeptidase (GGT). Both for H. pylori 
and H. suis, it has been hypothesized that the degradation of Gln and GSH may lead to a deficiency 
for the host, possibly initiating or promoting several pathologies. Therefore the in vivo effect of oral 
supplementation with Gln and GSH was assessed. Oral supplementation with Gln was shown to 
temper H. suis induced gastritis and epithelial (hyper)proliferation in Mongolian gerbils. Astonishingly, 
supplementation of the feed with GSH, another GGT substrate, resulted in inflammation and epithelial 
proliferation levels returning to baseline levels of uninfected controls. This indicates that Gln and GSH 
supplementation may help reducing tissue damage caused by Helicobacter infection in both humans 
and pigs, highlighting their potential as a supportive therapy during and after Helicobacter eradication 
therapy.
Non-Helicobacter (H.) pylori Helicobacter (NHPH) species have been found colonizing the stomach of 0.2–6% 
of humans patients with severe gastric complaints1. Infection causes gastritis and peptic ulceration and the rela-
tive risk of developing mucosa-associated lymphoid tissue (MALT) lymphoma has been described to be higher 
with NHPH than with H. pylori1,2. Several studies have shown that H. suis, a member of the H. heilmannii sensu 
lato (s.l.) group3, is the most prevalent gastric NHPH in humans, which has been described to account for 14% 
to 78.5% of NHPH infections4–6. Interestingly, experimental infection studies in rodent models of human gas-
tric disease have confirmed that long-term H. suis infection can lead to the development of gastric MALT lym-
phoma7–9. Besides humans, the majority of pigs worldwide are colonized by this bacterium, in which infection 
causes chronic gastritis and reduced average daily weight gain10. Transmission of H. suis most likely occurs 
through contact between pigs and humans1,11. Presence of viable H. suis bacteria in pork, however, suggests that 
foodborne infection might also occur12.
A persistent mild chronic gastritis can be observed in human patients after H. heilmannii s.l. eradication 
treatment with antibiotics and proton-pump-inhibitors11,13. For H. pylori, it has also been described that after 
successful eradication in humans, corpus gastritis and dysplasia improve, although they do not completely dis-
appear. Especially antral lesions seem non-responsive after eradication therapy14. This emphasizes the need for 
supplements that promote health of the gastric mucosa.
Recently, we and others identified the γ-glutamyltranspeptidase (GGT) from H. suis and H. pylori as an impor-
tant factor causing epithelial cell death and modulating lymphocyte responses15–18. For all gastric helicobacters, 
the mode of action of the GGT mostly depends on the breakdown of 2 substrates, glutathione (GSH) and glu-
tamine (Gln), both leading to the production of glutamate8,19–22. Under certain conditions, GGT-mediated degra-
dation of GSH facilitates the formation of reactive oxygen species, causing lipid peroxidation of cell membranes, 
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which ultimately leads to apoptosis or necrosis of gastric epithelial cells in vitro15. Depletion of Gln in vitro can 
lead to an impaired proliferation and dysfunction of T-lymphocytes16–18.
Gln and GSH have a broad range of functions in the host. Gln plays a crucial role in the energy supply 
of rapidly dividing cells, such as intestinal epithelial cells and cells of the immune system23. In addition, this 
amino acid plays a role in protein turn-over and purine and pyrimidine synthesis24,25. The tripeptide GSH 
(γ-L-glutamyl-L-cysteinylglycine) is synthesized intracellularly. This ubiquitous free thiol is not only impor-
tant for anti− oxidative protection of the plasma membrane and organelles, but it also plays distinct roles in 
cell cycle regulation and apoptosis26,27. After being transported outside the cells, GSH is degraded by eukaryotic 
membrane-bound GGT which removes the γ-glutamyl moiety28. The degradation products can be translocated 
into the cell, were they can for instance be recycled for GSH synthesis28.
Both deamination of Gln and degradation of GSH by Helicobacter GGT generate glutamate15,16,20, which can 
be taken up in the bacterial cell by a Na+-dependent transporter20,29. For H. pylori, metabolic reconstruction 
has suggested that glutamate can subsequently be converted to α -ketoglutarate, which can be channeled into 
the Tricarboxylic Acid cycle (TCA cycle)30. In contrast to most other bacteria, the TCA cycle of H. pylori is an 
atypical, non-cyclic pathway containing both an oxidative and reductive branch31. Some genes, necessary for a 
traditional TCA cycle are missing in the H. pylori genome. However, alternative reactions have been identified 
that allow connectivity between the metabolites of the TCA cycle30. No information is currently available on 
the metabolism of H. suis, a gastric Helicobacter species which is even far more fastidious than the well-studied 
H. pylori.
The present study is the first to examine the relative importance of the glutamate-generating metabolism 
(and by extension the amino acid metabolism) for survival and growth of H. suis. Since degradation of GSH and 
Gln by GGT from gastric helicobacters largely contribute to the glutamate-generating metabolism, we investi-
gated the effect of GGT substrate supplementation (Gln/GSH) on the outcome of an experimental H. suis infec-
tion in Mongolian gerbils. By correcting for possible imbalances, we aimed at reducing infection-related gastric 
pathologies.
Results
The glutamate-generating metabolism is vital for survival and growth of H. suis. Annotation 
of the H. suis genome identified no homologues for some important genes with a putative role in glucose metab-
olism21, suggesting that H. suis is unable to utilize the glycolytic pathway for metabolism. The genome of H. suis 
appears to lack glucose permease and several enzymes of the classic Embden-Meyerhof-Parnas pathway, includ-
ing glucokinase and phosphofructokinase21. Furthermore, most components of the Entner-Doudoroff pathway 
are absent in the H. suis genome, such as glucose 1-dehydrogenase and gluconate dehydratase21. Utilization of 
glucose was not observed during H. suis culture in both Minimal Essential medium (MEM) and Mueller Hinton 
(MH) medium (Fig. 1, Table S1), further suggesting this bacterium does not utilize glucose as a major energy 
source.
Instead, we hypothesized that this bacterium has to rely on other sources for its energy production. Pyruvate 
occupies a central branch point in the energy metabolism of H. suis. As the glycolytic pathway is impaired, 
pyruvate is most likely generated from amino acids such as serine, alanine and cysteine. This hypothesis was 
confirmed when we found that incubation of H. suis for 24 hours in MEM significantly lowered the extracellu-
lar concentrations of serine (p < 0.001), alanine (p < 0.001) and cysteine (p < 0.001). A decrease (up to 6-fold) 
of these amino acids was observed, probably due to the generation of pyruvate. In contrast, in MH-medium 
only cysteine concentrations significantly decreased (p < 0.001), whereas serine and alanine concentrations 
remained steady over time (Fig. 2). Genome annotation (using RAST) showed the presence of homologues for 
Figure 1. Carbohydrate concentrations in the supernatant of a liquid Helicobacter suis culture. Minimal 
Essential Medium (MEM) and Mueller Hinton (MH) medium. The y-axis represents the fold change of the 
different carbohydrates relative to the 2 hour measurement point.
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H. pylori genes encoding for L-serine deaminase (Accession number: NC.000915.1, gen ID 900301), cystathio-
nine γ -synthase (NC.000915.1, gene ID 898970), alanine racemase (NC.000915.1, gen ID 899470) and D-amino 
acid dehydrogenase (NC.000915.1, gen ID 899472) in the H. suis genome (respective locus tags: HSUHS1_
RS00280, HSUHS1_RS06050, HSUHS1_RS00415 and HSUHS1_0061)21. Another amino acid that was decreased 
to basal levels after 24 h incubation in MEM was proline (p = 0.001, Fig. 2). We hypothesize that, as described 
for H. pylori, proline is taken up by the bacteria from the extracellular medium—mediated by the proline per-
mease PutP32 – and subsequently converted to glutamate inside the bacteria by the proline utilizing flavoenzyme 
A (PutA)32,33. A homologue of the putP gene of H. pylori (NC.00915.1, gen ID 899191) is indeed present in the 
genome of H. suis (locus tag HSUHS1_1153)21. No significant changes were detected for this amino acid when 
H. suis was incubated in MH-medium.
Other substrates that decreased over time in the culture supernatant included malate and lactate. In MEM, 
lactate levels significantly decreased (p < 0.001). In MH-media, lactate, as well as malate concentrations decreased 
(resp. p = 0.001 and p < 0.001, Fig. 1). They showed up to a 7-fold reduction after H. suis culture, suggesting they 
may also be important carbon sources. A homologue for the H. pylori gene encoding for D-lactate dehydrogenase 
(NC.000915.1, gene ID 898825) is also present in the H. suis genome (locus tag HSUHS5_RS01825)21, allowing 
the conversion of lactate to pyruvate.
Pyruvate can subsequently be converted to acetyl-CoA by pyruvate synthase. For H. pylori, it has been 
described that the main route for pyruvate assimilation is via a pyruvate:flavodoxin oxidoreductase (POR) 
(NC.00915.1, gen ID 899646)34. ORF’s have been identified in the H. suis genome encoding a POR-type pyruvate 
synthase (pyruvate oxidoreductase: HSUSH1_RS06160, phosphoenolpyruvate synthase: HSUHS1_RS07385)21, 
suggesting that a similar mechanism is present in H. suis. As described for H. bizzozeronii, the genome of H. suis 
also codes for phosphoenol pyruvate carboxylase (locus tag HSUHS1_RS00640)21, an enzyme that plays a role in 
the synthesis of oxaloacetate from phosphoenolpyruvate35.
Certain amino acids were nearly depleted from the medium of a 24 h culture of H. suis. The levels of aspar-
agine decreased approximately 50-fold (p < 0.001, Fig. 2), while the level of Gln dropped below the detection 
limit (p < 0.001, Fig. 2). Metabolic reconstruction showed that homologs for HP-ansB/HP-dcuA and HP-ggt/
HP-gltS are present in the H. suis genome21. For H. pylori, these hydrolysis/transport systems have been shown 
to be responsible for the deamination of asparagine and Gln and subsequent uptake by the bacteria of aspar-
tate and glutamate, respectively29. These amino acids not only serve as precursors to protein synthesis, they can 
also be metabolized as energy source via the TCA cycle. Indeed, a homologue for the H. pylori gene coding for 
NADP-dependent glutamate dehydrogenase (NC.000915.1, gen ID 898871) is present in the genome of H. suis 
(locus tag HSUHS1_RS07485)21. This enzyme can convert glutamate to 2-ketoglutarate, an intermediate metabo-
lite of the TCA cycle, whereas aspartate can be channeled into the TCA cycle by aspartate ammonia-lyase or other 
multi-step pathways, such as adenylosuccinate synthase—adenylosuccinate lyase. In any case, this underlines the 
Figure 2. Amino acid concentrations in the supernatant of a liquid Helicobacter suis culture. Shown are 
the relative fold changes of the different amino acid concentrations compared to the 2 hour measurement point. 
MEM = Minimal Essential Medium, MH = Mueller Hinton.
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importance of the amino acid metabolism and Gln metabolism in particular for the growth and energy supply 
of H. suis. A more detailed report of the metabolites used by H. suis in both the MEM- and MH-medium can be 
found in supplementary Table S1.
Degradation of Gln and GSH by Helicobacter suis GGT. H. suis GGT (HsGGT) and H. pylori GGT 
(HpGGT) were shown to have a very similar Gln- and GSH-degrading capacity. After 2 hours of incubation, 
3.88 ± 0.01 μ g/ml and 4.23 ± 0.02 μ g/ml ammonia was generated by Gln degradation through 2 μ g/ml HsGGT 
and HpGGT, respectively. After 6 hours of incubation, slightly higher amounts of ammonia were generated 
(4.30 ± 0.06 μ g/ml and 4.95 ± 0.02 μ g/ml, respectively) (Fig. 3).
After 8 hours of incubation, the initial GSH concentration was reduced by 80%, which added up to 97% after 
24 h. Comparable data were obtained for HpGGT. After 8 h, the GSH concentration was reduced by 75%, whereas 
after 24 h the GSH concentration was reduced by 95% (Fig. 4).
GSH and Gln supplementation drastically reduces Helicobacter-induced inflammation and cell 
damage. Given the importance of the glutamate-generating metabolism for H. suis and the potential impact 
of the concurrent Gln and GSH degradation (with an important role for H. suis GGT in these processes), we 
investigated the effects of feed supplementation with both substrates to H. suis infected Mongolian gerbils.
No differences in feed intake were observed between animals from different groups during the experiment 
(p > 0.05, Table S2). In addition, animals in different groups showed a similar weight gain during the course of 
the experiment (Table S2). All uninfected control animals tested negative for the presence of H. suis. In experi-
mentally infected animals, the highest H. suis colonization rates were found in the antrum. Average colonization 
rates in animals receiving the standard diet, Gln-supplemented and GSH-supplemented diet were 2.49 × 104 
Figure 3. Production of ammonia during Helicobacter suis/H. pylori GGT-mediated degradation of 
glutamine. 
Figure 4. Degradation of GSH by Helicobacter suis GGT (HsGGT) and H. pylori GGT (HpGGT). After 
supplementing 2 μ g/ml HsGGT or HpGGT to Ham’s F12 containing 1600 µg/ml glutathione (GSH), a decrease 
in GSH concentration was observed.
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(± 2.76 × 104), 1.13 × 104 (± 6.08 × 104) and 2.62 × 103 (± 5.53 × 103) bacteria/mg tissue, respectively. There were 
no statistically significant differences between different groups, although animals receiving the GSH diet tended 
to show lower colonization rates (Standard vs Gln p = 0.606; Standard vs GSH p = 0.129, Fig. S1).
None of the control animals showed signs of gastritis. In H. suis infected animals, gastritis was mainly pres-
ent in the antrum. There was a significant difference in gastritis scores between the different groups of infected 
animals (Fig. 5). A detailed overview of the observed inflammation scores can be found in the online supple-
mentary data (Table S3). Infected animals belonging to the group receiving the GSH supplemented diet showed 
Figure 5. Average gastritis scores observed in the antrum of the stomach of H. suis infected animals 
shows a markedly decreased inflammation in the group receiving the glutathione diet (GSH). An *depicts 
significantly lower values compared to the H. suis infected animals receiving the standard feed. Error bars 
represent the standard deviation.
Figure 6. Proliferating lymphocytes in the antrum of control (a)and Helicobacter suis infected animals 
(b–d). Proliferation of lymphocytes, as well as the formation of lymphoid follicles with proliferating germinal 
centers, is observed in H. suis infected animals receiving the standard diet (b) and infected animals receiving the 
glutamine-supplemented diet (c). In contrast, only a limited amount of proliferating lymphocytes are observed 
in H. suis infected animals receiving the diet supplemented with glutathione (d). In control animals (a), only a 
limited number of cells are proliferating and no lymphocytic aggregates are present. Proliferating Ki-67 positive 
cells are brown.
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substantially lower inflammation scores (mean score 0.3 ± 0.4; Fig. 6D) compared to infected animals from the 
group receiving the purified standard diet (mean score 2.6 ± 0.4; p < 0.001; Fig. 6B). Seven out of 10 H. suis 
infected animals receiving the GSH-supplemented diet even showed no detectable inflammation. Although 
notably less lymphocytic infiltration and fewer lymphocytic aggregates were also observed in the infected ani-
mals receiving the Gln supplemented diet (mean score 1.9 ± 0.9; Fig. 6C), this was not statistically significant 
(p = 0.064). In general, deep lymphocytic infiltrates consisted mainly of CD3-positive cells whereas superficial 
lymphoid follicles contained a majority of CD3-negative B lymphocytes (Fig. S2).
Results of cytokine expression are summarized in Fig. 7. For most cytokines tested, no differences were 
observed between control groups receiving different diets. Surprisingly, however, uninfected control animals 
receiving the Gln-supplemented diet did show an upregulation of INF-γ expression (p = 0.012, fold = 3.01 ± 1.19).
When comparing control and H. suis infected animals, both receiving the standard diet, H. suis infection was 
shown to provoke an upregulation of IL-1β , INF-γ and IL-10 expression. In H. suis infected animals receiving 
the Gln-supplemented diet, only an upregulation of IL-1β was noted, whereas mRNA expression levels of other 
cytokines dropped back to the levels of uninfected control animals. Animals receiving the GSH diet even showed 
cytokine expression levels comparable to those in uninfected control animals.
No differences in epithelial cell proliferation were observed between the non-infected groups receiving dif-
ferent diets. Marked differences in terms of gastric epithelial proliferation at the level of the antral pits were 
observed between H. suis infected groups receiving different diets (Figs 8 and 9). H. suis infected animals receiv-
ing the standard diet showed the highest epithelial proliferation rate (8.2 ± 1.0 Ki67-positive cells per gland; 
p < 0.001). The proliferation rate was significantly lower in animals receiving the Gln- (6.2 ± 1.1, p = 0.010) or 
the GSH-supplemented diet (4.9 ± 1.6, p = 0.002) compared to infected animals receiving the non-supplemented 
diet. In the corpus, no differences in epithelial cell proliferation were observed between the different H. suis 
infected groups (Fig. 9).
Besides their abundant presence in the corpus, a limited number of parietal cells can also be found in the 
antrum. An abrupt loss of parietal cells was observed in the transition zone between the corpus and antrum in 
the H. suis infected animals receiving the standard diet as well as the Gln-supplemented diet. In H. suis infected 
animals receiving the GSH-supplemented diet, this abrupt loss was absent, revealing an image comparable to that 
of uninfected control animals (Fig. S3).
Discussion
Metabolic profiling and the absence of putative genes encoding important enzymes of the Embden-Meyerhof- 
Parnas and Entner-Doudoroff pathway suggest that, in contrast to the closely related H. pylori and H. bizzozero-
nii, H. suis is not able to utilize glucose for its main energy supply. As a consequence, H. suis has to rely on other 
sources to fulfill its energy requirements. Metabolic reconstruction and analysis of metabolites in H. suis culture 
medium showed that H. suis tends to use amino acids, not only for protein synthesis, but most likely also as an 
energy source. The consumption of amino acids was obvious in cultures grown in both liquid media, but was 
most pronounced in MEM, which can be considered to be the most basic one of the two. This could indicate that 
H. suis relies even more on amino acids for its survival when facing stressful situations.
One of the preferred nutrients seems Gln, which is the most abundant free amino acid in both plants and ani-
mals36–38. Our current and previous studies have shown that Gln is depleted from the medium during H. suis cul-
ture due to the hydrolysis by H. suis GGT16. As described for H. pylori, the formed glutamate can be taken up and 
converted to 2-ketoglutarate by the bacteria and channeled into the TCA cycle21,29, an important metabolic path-
way that provides precursors for a variety of cell components, as well as for supplying energy to the bacterium31.
Figure 7. Fold change in cytokine expression in control and Helicobacter suis infected animals. An *indicates 
a significant difference in infected animals compared to the negative control animals receiving the standard diet. 
An °indicates a significant difference in expression compared to H. suis infected animals receiving the standard 
diet (p < 0.05). Std: animals receiving the standard diet; Gln: Glutamine-supplemented diet; GSH: Glutathione-
supplemented diet.
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The hydrolysis of extracellular Gln by the GGT from gastric helicobacters can cause a depletion of this con-
ditionally essential amino acid in the gastric juice of an infected host, which may eventually lead to epithelial cell 
damage and immunological dysfunction16,18,20. By supplementing Gln to the diet of Mongolian gerbils we aimed 
Figure 8. Proliferating Ki67-positive (brown) epithelial cells and lymphocytes in the antrum of the 
stomach of control and Helicobacter suis infected animals. (a) Control animal receiving the standard diet; 
(b) H. suis infected animal receiving the standard diet; (c) H. suis infected animal receiving the glutamine-
supplemented diet; (d) H. suis infected animal on the glutathione-supplemented diet. A more pronounced 
proliferation is observed in H. suis infected animals receiving the standard and glutamine-supplemented diet 
compared to H. suis infected animals receiving the glutathione-supplemented diet.
Figure 9. Proliferation of gastric epithelial cells. Ki67 staining of the stomach epithelium in the antrum and 
corpus of the stomach. Std: standard feed, Gln: glutamine-supplemented feed, GSH: glutathione-supplemented 
feed. An *depicts significantly lower values compared to the H. suis infected animals receiving the standard feed. 
Error bars represent the standard deviation.
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at reducing inflammation-related as well as other Helicobacter-related gastric pathological changes. In addition to 
a local effect, dietary Gln supplementation has been described to cause an increase of the systemic Gln concen-
tration, which may also sustain the health and function of immune and epithelial cells39. The role of Gln in gastric 
mucosal protection against H. pylori infection has been reported previously36–38,40–42. In these studies, an effect 
of Gln supplementation on gastric inflammation and cytokine expression was observed41. In addition, a recent 
study indicated that the depletion of Gln, as a result of high GGT activity, might actually be responsible for the 
strong inflammatory response following H. pylori infection, as shown by increased release of pro-inflammatory 
IL-8 from epithelial cells17. In contrast, Wüstner et al.18 described that H. pylori GGT activity leads to an impaired 
T-cell function by depriving activated lymphocytes from Gln.
In the present study, the beneficial effect of Gln supplementation on inflammation was only mild to moderate, 
which may be due to the shorter infection period compared to that described by Hagen et al.41. Nevertheless, 
H. suis infected animals receiving the Gln diet showed smaller gastric lymphoid follicles and less diffuse lymphoid 
infiltration compared to the animals receiving the standard diet. This decreased proliferation of lymphocyte pop-
ulations, as well as the reduced expression of pro- and anti-inflammatory cytokines in H. suis infected animals 
receiving Gln-supplemented feed is somewhat in contrast to in vitro studies showing that Gln supplementation 
restores the impaired proliferation of H. suis GGT-treated Jurkat T-cells16. Other factors are most likely involved, 
such as a protective effect of Gln on the epithelial barrier.
Indeed, the current study is the first to show a direct effect of Gln supplementation on the proliferation 
rate of gastric epithelial cells in the context of a Helicobacter infection, suggesting a protective effect of Gln on 
gastro-intestinal epithelial cells43–45. Most likely, hyperproliferation of epithelial cells found in H. suis infected 
animals receiving the standard diet is a secondary response to increased cell death induced by this bacterium8,45,46. 
Increased cell death may be induced by an increased oxidative stress burden or a modification of the redox bal-
ance of gastric epithelial cells following Gln depletion15,47. Supplementing Gln may therefore assist in restoring the 
redox balance. Besides oxidative stress, H. suis infection causes a dramatic increase of ammonia concentrations, 
resulting from urease and GGT activity of the bacterium1,20,42,48. Adding Gln to the diet can stimulate arginase 
activity, causing a conversion of ammonia to the less toxic urea, and helping in clearing ammonia from the cells by 
stimulating its excretion23,42. Although it apparently has a beneficial effect on compensatory hyperproliferation of 
gastric epithelial cells, supplementing Gln to H. suis infected animals does not prevent the abrupt loss of parietal 
cells at the transition zone between the corpus and antrum8.
Besides a depletion of Gln, GGT from gastric helicobacters also causes degradation of GSH15,16. Previous 
in vitro research has revealed that supplementation of GSH at a concentration of 5 mM to H. suis GGT-treated epi-
thelial cells can stimulate the formation of pro-oxidative GSH degradation products and extracellular oxygen rad-
icals, leading to necrosis of damaged cells15. In the present study, however, supplementing 0.8% GSH to the diet 
of H. suis infected gerbils revealed tremendously beneficial effects on the health of a Helicobacter-infected stom-
ach. We observed a marked decrease of gastric epithelial cell proliferation rates, protection against parietal cell 
death and a 90% reduction of gastritis, accompanied by normalized expression levels for all (pro-inflammatory) 
cytokines, confirming the suppression of the host immune response elicited by Helicobacter infection. Only three 
animals had small lymphoid follicles in the antrum of the stomach, despite normal H. suis colonization rates. 
Helicobacter GGT has been shown to inhibit proliferation of T-lymphocytes, an effect that has been suggested to 
play a role in the immune escape by these bacteria16,49. Supplementing GSH to the cell medium has been shown to 
aggravate this effect16. Possibly, similar mechanisms are involved in the current in vivo study.
The observed protective effects on infection-induced inflammation and, surprisingly, epithelial cell hyperpro-
liferation may be explained by a dose-dependent effect of GSH. Intracellular concentrations of GSH are usually 
very high, ranging from 0.5 to 10 mM, whereas extracellular concentrations are found in the micromolar range50. 
Therefore, supplementing feed with higher concentration of GSH (35 mM) compared to the dosages used for pre-
vious in vitro studies (5 mM)15 probably results in an excess quantity of protective extracellular GSH, most likely 
counterbalancing some potentially negative effects on gastric epithelial cell health by GGT-induced generation of 
pro-oxidative GSH degradation products15. It has indeed been shown that, when available for the host cells, GSH 
plays an important role in the protection of cells against oxygen radicals, detoxification and metabolisation of var-
ious endo- and exogenous compounds, cell cycle regulation, cell signaling and apoptosis16,50–52. GSH deficiency 
makes cells more sensitive to oxidative stress and can cause degeneration of epithelial cells50,51. The remarkable 
beneficial effects of GSH on Helicobacter-induced inflammation and epithelial cell homeostasis suggest that GSH 
supplementation could be considered as a supportive therapy during and even after a Helicobacter eradication 
therapy. It should be noted, however, that only the short/medium-term effects of GSH supplementation were 
evaluated during this trial. A study of Liu et al.53 showed that GSH supplementation had beneficial effects on acute 
clinical signs of inflammatory bowel disease (IBD), whereas some adverse effects were observed in the chronic 
stages of IBD in this particular disease model. More research is therefore needed to evaluate the long-term safety 
and effects of GSH supplementation and to make recommendations on the chronic use of glutathione in people 
suffering from gastric disease.
Feed additives are commonly used in the pig industry to promote pig health. They are easily manufactured 
and provided to the animals. Both Gln and GSH can be considered as a possible feed additive since the con-
centrations of both were shown to be stable in the feed pellets used in the present study (unpublished results). 
These supplements may therefore be helpful for decreasing both the prevalence and severity of gastric pathologies 
caused by H. suis infection in pigs. Indeed, up to 90% of H. suis infected pigs have been shown to develop gastritis, 
which most likely plays a role in the observed reduction of daily weight gain, a primordial production character-
istic in the pig industry10.
In conclusion, we showed that H. suis preferably uses amino acids to meet its energy requirements. In particu-
lar, the glutamate-generating metabolism seems essential, as shown by a complete depletion of Gln during H. suis 
culture. The H. suis GGT has previously been shown to be an important factor degrading Gln, but also GSH. Oral 
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supplementation of H. suis infected animals with these two substrates, Gln or GSH, resulted in a marked reduc-
tion of infection-related gastric pathologies, both related to inflammation and epithelial cell damage. GSH was 
shown to be superior to glutamine and may prove to be of therapeutic value for use in both humans and animals.
Methods
Metabolic Profiling of H. suis: Energy Metabolism. H. suis type strain HS1LP was grown in liquid 
Minimal Essential Medium (MEM) and Mueller Hinton (MH) broth. The sample preparation process was car-
ried out using the automated MicroLab STAR® system (Hamilton Company, Reno, US). Recovery standards 
were added prior to the first step in the extraction process for Quality Control purposes. Sample preparation 
was conducted using a proprietary (Metabolon, Durham, North Carolina, USA) series of organic and aqueous 
extractions to remove the protein fraction while allowing maximum recovery of small molecules. The resulting 
extract was divided into two fractions, one for analysis by Liquid Chromatography (LC) and one for analysis by 
gas chromatography (GC). Samples were placed briefly on a TuboVap® (Zymark, Massachusetts, US) to remove 
the organic solvent. Each sample was then frozen and dried under vacuum. Samples were then prepared for the 
appropriate instrument, either LC/MS or GC/MS.
The LC/MS portion of the platform was based on a Surveyor HPLC and a Thermo-Finnigan LTQ Fmass 
spectrometer (Thermo scientific, Waltham, Massachusettes, USA), which consisted of an electrospray ionization 
(ESI) source and linear ion-trap (LIT) mass analyzer. Positive and negative ions were monitored within a single 
analysis by consecutively alternating the ionization polarity of adjacent scans. The vacuum-dried sample was dis-
solved in 100.0 μ l of an injection solvent that contained five or more injection standards at fixed concentrations. 
The chromatography has been standardized by Metabolon, Inc. and once a method was validated, no changes 
were made to it. The internal standards were used both to assure injection and chromatographic consistency. The 
chromatographic system used a binary solvent (water and methanol) system delivered as a gradient. The HPLC 
columns were washed and reconditioned after every injection.
The samples destined for GC/MS analysis were re-dried under vacuum desiccation for a minimum of 24 hours 
prior to being derivatized under dried nitrogen using bistrimethyl-silyl-triflouroacetamide (BSTFA). The GC 
column was 5% phenyl and the temperature ramp ranged from 40° to 300 °C in a 16 minute period. Samples were 
analyzed on a Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using electron 
impact ionization.
At 2, 12, 18 and 24 hours media supernatants was analyzed. For each condition, 4 biological replicates were 
performed. A small aliquot of each experimental sample for a specific matrix was obtained and pooled. These 
pooled samples were injected throughout the platform day run and served as technical replicates.
In total, 702 media were identified and statistical analysis was performed to detect concentration changes 
during H. suis culture. Based on information derived from a draft genomic sequence21, a partial metabolic recon-
struction of H. suis strains HS1 and HS5 (currently named H. suis strains HS1LP and HS5bLP54) was performed, 
mainly focusing on the carbon metabolism of this bacterium and attempting to confirm the results of metabolic 
profiling (Integrated Genomics Inc., Chicago, Illinois, US).
In addition, the RAST (Rapid Annotation using Subsystem Technology) tool was used to confirm the pres-
ence/absence of genes important for the metabolism of H. suis in the genome of H. suis strains HS1LP and 
HS5bLP21,54.
Effects of H. suis and H. pylori GGT on Gln and GSH. The H. suis and H. pylori GGT were expressed and 
purified as described previously15. Both enzymes were compared to each other regarding their capacity to degrade 
2 important substrates: Gln and GSH. Two μ g/ml of H. suis or H. pylori GGT was added to HBSS supplemented 
with 2 mM Gln and incubated at 37 °C for 2 hours and 6 hours. As a control, a solution of HBSS supplemented 
with 2 mM Gln was used. The concentration of produced ammonia was detected using an Ammonia Assay Kit 
(Abcam, Cambridge, UK) according to the manufacturer’s instructions.
To evaluate the effect of HsGGT and HpGGT on GSH, 1600 µg/ml GSH was incubated for 8–24 hours at 37 °C 
with 2 μ g/ml HsGGT or HpGGT in Ham’s F12 medium. GSH concentration was measured using the Glutathione 
Assay Kit (Sigma-Aldrich) according to the manufacturer’s instructions.
Bacterial strain used for in vivo experimentation. H. suis strain HS5bLP, isolated from the gastric 
mucosa of a sow55, was used for experimental infection of Mongolian gerbils. Culture was performed as described 
previously54.
Ethics statement. All experimental procedures were approved by the Ethical Committee of the Faculty of 
Veterinary Medicine of the University of Ghent, Belgium (approval number EC2011-113), and carried out in 
accordance with the approved guidelines and regulations.
Animals, housing, inoculation and sampling. Sixty female Mongolian gerbils (Charles River, France) 
arrived at our animal housing units at the age of 4 weeks. They were randomly divided in 6 groups with 10 animals 
each. Animals from 1 group were divided in 2 filter-top cages (5 animals each), all held in the same stable under 
controlled environmental conditions. During the experiment, feed intake was monitored weekly and body weight 
was measured three times, twice at inoculation and once at euthanasia.
Three different rodent diets (Table 1) were provided ad libitum to 20 animals each (Research Diets, Inc., New 
Brunswick, USA). The standard diet was a purified feed (AIN-93 G, Research Diets, Inc.). The other 2 diets were 
identical to the standard diet, with the exception of being supplemented with 5% Gln or 0.8% GSH and with a 
variable amount of corn starch, used to correct minor differences in the energy content. At the age of 6 weeks, 
the animals were briefly anaesthetized with 3% isoflurane and inoculated intragastrically twice, with a two-day 
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interval. Ten animals from each feed group received 8 × 107 viable H. suis bacteria/dose. The remaining 10 ani-
mals/feed group were sham-inoculated with the culture medium of H. suis.
Twelve weeks after the first inoculation, animals were anaesthetized with 5% (vol/vol) isoflurane followed by 
cervical dislocation. The stomach was opened along the greater curvature. A longitudinal strip was taken from 
the forestomach to the duodenum, fixed in 4% phosphate buffered formaldehyde and embedded in paraffin for 
histopathological examination. Biopsies from antrum and corpus were taken for DNA and RNA extraction. These 
tissues were immediately submerged in RNAlater (Qiagen, Hilden, Germany) and stored at −70 °C until further 
processing.
DNA extraction and quantitative-PCR to determine the colonization rate of H. suis. DNA 
extraction and Quantitative-PCR were performed on the DNA samples as described previously56,57.
Standard diet
Gln-supplemented 
diet
GSH-supplemented 
diet
Gram% Kcal% Gram% Kcal% Gram% Kcal%
Protein 20 20 25 25 20 20
Carbohydrate 64 64 59 59 63 64
Fat
7 16 7 16 7 16
Gram Kcal Gram Kcal Gram Kcal
Casein 200 800 200 800 200 800
L-Cystine 3 12 3 12 3 12
Supplemented L-Glutamine 0 0 50 200 0 0
Corn Starch 397.486 1590 374.486 1390 397.486 1590
Maltodextrin 132 528 132 528 132 528
Sucrose 100 400 100 400 100 400
Cellulose 50 0 50 0 50 0
Soybean oil 70 360 70 360 70 360
Mineral Mix 35 0 35 0 35 0
Vitamin Mix 10 40 10 40 10 40
Choline Bitartrate 2.5 0 2.5 0 2.5 0
Supplemented Glutathione 0 0 0 0 8.07 0
Total 1000 4000 1000.05 4000 1008.12 4000
Table 1.  Composition of the 3 different diets used in this study.
Cytokine Primers Sequence (5′ → 3′) Reference
IL-17
F: AGC TCC AGA GGC CCT CGG AC
59
R: AGG ACC AGG ATC TCT TGC TG
TNF-α 
F: GCT CCC CCA GAA GTC GGC G
59
R: CTT GGT GGT TGG GTA CGA CA
IL-10
F: GGT TGC CAA GCC TTA TCA GA
56
R: GCT GCA TTC TGA GGG TCT TC
IL-1β 
F: GGC AGG TGG TAT CGC TCA TC
Modified from59,
R: CAC CTT GGA TTT GAC TTC TA
IL-5
F: AGA GAA GTG TGG CGA GGA GAG ACG
Present study
R: ACA GGG CAA TCC CTT CAT CGG
IL-6
F: CAA AGC CAG AGC CAT TCA GAG
56
R: GCC ATT CCG TCT GTG ACT CCA GTT TCT CC
IL-12p40
F: GAC ACG ACC TCC ACC AAA GT
56
R: CAT TCT GGG ACT GGA CCC TA
IFN-γ 
F: CCA TGA ACG CTA CAC ACT GCA TC
60
R: GAA GTA GAA AGA GAC AAT CTG G
Β -actin
F: TCC TCC CTG GAG AGG AGC TA
61
R: CCA GAC AGC ACT GTG TTG GC
HPRT
F: CTC ATG GAC TGA TTA TGG ACA G
61
R: AGC TGA GAG ATC ATC TCC ACC AAT
Table 2.  Forward (F) and reverse (R) primers used for cytokine-expression.
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RNA extraction and Real-Time PCR analysis of cytokine expression. After separation of DNA and 
RNA, the latter was further purified using the RNeasy Mini kit (Qiagen) following the suppliers’ instructions. 
Synthesis of cDNA was done by using the iScriptTM cDNA synthesis kit (Bio-rad, Hercules, USA) as described 
by the manufacturer. Real Time− PCR and melting curve analysis were done as described before58. The primer 
sequences are summarized in Table 2. Primers for interleukin (IL)-5 were designed using primer3 software.
Histopathology. Four sections of 5 μ m were sliced from the paraffin-embedded stomach tissue. The first 
section was used for a hematoxylin and eosin (HE) staining to score the intensity of infiltration with mononuclear 
and polymorphonuclear cells. A second tissue slide was stained using a mouse monoclonal anti-Ki67 antibody 
(Menarini Diagnostics, Firenze, Italy; dilution 1:50) and a biotinylated goat anti-mouse IgG antibody to iden-
tify proliferating cells. Positive cells lining the lumen of the gastric pits were counted in five randomly chosen 
High Power Fields (magnification: x400) in the corpus and antrum. For each animal, an average of the positive 
cell count was determined for both stomach regions. A third section was used to stain acid-producing parietal 
cells of the corpus of the stomach by using an antibody directed against the H+K+ATP− ase β -subunit (Abcam, 
Cambridge, UK; dilution 1:25000). The fourth tissue slide was used for visualization of T-lymphocytes, by using 
an antibody directed against CD3 (Abcam, dilution 1:100).
Statistical analysis. T-tests were used to analyze the data of the metabolomics study. T-test comparisons 
were performed between each experimental group and its control.
Differences in gastritis between experimentally infected animals and control animals receiving the standard 
diet were analyzed using a Mann-Whitney U non-parametric test. Comparison of the colonization rates, cytokine 
expression and epithelial proliferation rates between the different diet groups of infected animals was done by 
means of a one-way ANOVA (SPSS 21, IBM, New York, USA). P-values ≤ 0.05 were considered statistically sig-
nificant. When multiple groups were compared, a Bonferroni correction was made. All data are expressed as 
mean ± standard deviation.
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